Application
SLC5A1 Antibody (C-term) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the SLC5A1 antibody detected the SLC5A1 protein (arrow).| Product Name | SLC5A1 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SLC5A1; NAGT; SGLT1; Sodium/glucose cotransporter 1; High affinity sodium-glucose cotransporter; Solute carrier family 5 member 1 |
| Conjugation | Agarose |
| Modification | Acetylated |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | ELISAICC/IFIHCWB |
| WB:1:100~500 |
|
| Species Reactivity | HumanMousePorcineRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | NAGT SGLT1 |
|---|---|
| Alternative Names | SLC5A1 NAGT SGLT1 Sodium/glucose cotransporter 1 High affinity sodium-glucose cotransporter Solute carrier family 5 member 1 |
| Molecular Weight(MW) | 73498 Da |
| Function | Actively transports glucose into cells by Na(+) cotransport with a Na(+) to glucose coupling ratio of 2:1 Efficient substrate transport in mammalian kidney is provided by the concerted action of a low affinity high capacity and a high affinity low capacity Na(+)/glucose cotransporter arranged in series along kidney proximal tubules |
| Tissue Specificity | Expressed mainly in intestine and kidney. |
| Cellular Localization | Membrane; Multi-pass membrane protein. |
| Entrez Gene | 6523 |
|---|---|
| Nucleotide Accession | NP_000334.1 |
Application
SLC5A1 Antibody (C-term) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the SLC5A1 antibody detected the SLC5A1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
